Activation of PKC epsilon induces lactotroph proliferation through ERK1/2 in response to phorbol ester

Molecular and Cellular Endocrinology

Volumn 289, Issue 1-2, 2008, Pages 77-84

  Petiti, Juan Pablo ^a   De Paul, Ana Lucía ^a   Gutiérrez, Silvina ^a   Palmeri, Claudia Mariela ^a   Mukdsi, Jorge Humberto ^a   Torres, Alicia Inés ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

ERK1 2; Lactotroph; PKC ; PKC ; PMA; Proliferation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BISINDOLYLMALEIMIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C ALPHA; PROTEIN KINASE C EPSILON;

ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; INCUBATION TIME; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROLACTIN SECRETING CELL; RAT;

EID: 45049087930     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.04.015     Document Type: Article

References (54)

1. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., and Saltiel A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270 46 (1995) 27489-27494
2. Alvaro V., Touraine P., Raisman Vozari R., Bai-Grenier F., Birman P., and Joubert D. Protein kinase C activity and expression in normal and adenomatous human pituitaries. Int. J. Cancer. 50 5 (1992) 724-730
3. Asa S.L., and Ezzat S. The pathogenesis of pituitary tumours. Nat. Rev. Cancer. 2 11 (2002) 836-849
4. Bae K.M., Wang H., Jiang G., Chen M.G., Lu L., and Xiao L. Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner. Cancer Res. 67 13 (2007) 6053-6063
5. Ballester R., and Rosen O.M. Fate of immunoprecipitable protein kinase C in GH3 cells treated with phorbol 12-myristate 13-acetate. J. Biol. Chem. 260 28 (1985) 15194-15199
6. Basu A., and Sivaprasad U. Protein kinase C epsilon makes the life and death decision. Cell. Signal. 19 8 (2007) 1633-1642
7. Caughlan A., Newhouse K., Namgung U., and Xia Z. Chlorpyrifos induces apoptosis in rat cortical neurons that is regulated by a balance between p38 and ERK/JNK MAP kinases. Toxicol. Sci. 78 1 (2004) 125-134
8. Chaturvedi K., and Sarkar D.K. Mediation of basic fibroblast growth factor-induced lactotropic cell proliferation by Src-Ras-mitogen-activated protein kinase p44/42 signaling. Endocrinology 146 4 (2005) 1948-1955
9. Collazos A., Diouf B., Guerineau N.C., Quittau-Prevostel C., Peter M., Coudane F., Hollande F., and Joubert D. A spatiotemporally coordinated cascade of protein kinase C activation controls isoform-selective translocation. Mol. Cell. Biol. 26 6 (2006) 2247-2261
10. Csukai M., Chen C.H., De Matteis M.A., and Mochly-Rosen D. The coatomer protein beta'-COP, a selective binding protein (RACK) for protein kinase Cepsilon. J. Biol. Chem. 272 46 (1997) 29200-29206
11. De Paul A., Pons P., Aoki A., and Torres A. Different behavior of lactotroph cell subpopulations in response to angiotensin II and thyrotrophin-releasing hormone. Cell. Mol. Neurobiol. 17 2 (1997) 245-258
12. Dokladda K., Green K.A., Pan D.A., and Hardie D.G. PD98059 and U0126 activate AMP-activated protein kinase by increasing the cellular AMP:ATP ratio and not via inhibition of the MAP kinase pathway. FEBS Lett. 579 1 (2005) 236-240
13. Dorn G.W., and Mochly-Rosen D. Intracellular transport mechanisms of signal transducers. Annu. Rev. Physiol. 64 (2002) 407-429
14. Eichholtz T., Bont D.B., Widt J., Liskamp R.M., and Ploegh H.L. A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor. J. Biol. Chem. 268 3 (1993) 1982-1986
15. Garrido-Gracía J.C., Bellido C., Aguilar R., and Sanchez-Criado J.E. Protein kinase C cross-talk with gonadotrope progesterone receptor is involved in GnRH-induced LH secretion. J. Physiol. Biochem. 62 1 (2006) 35-42
16. Greco S., Elia M.G., Muscella A., Romano S., Storelli C., and Marsigliante S. Bradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture. J. Endocrinol. 186 2 (2005) 291-301
17. Griner E.M., and Kazanietz M.G. Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer 7 4 (2007) 281-294
18. Gutiérrez S., Petiti J.P., De Paul A.L., Mukdsi J.H., Aoki A., Torres A.I., and Orgnero E.M. Antagonic effects of oestradiol in interaction with IGF-1 on proliferation of lactotroph cells in vitro. Histochem. Cell. Biol. 124 3/4 (2005) 291-301
19. Gutiérrez S., De Paul A.L., Petiti J.P., Del Valle Sosa L., Palmeri C.M., Soaje M., Orgnero E.M., and Torres A.I. Estradiol interacts with insulin through membrane receptors to induce an antimitogenic effect on lactotroph cells. Steroids 73 5 (2008) 515-527
20. Hamilton H.B., Hinton D.R., Law R.E., Gopalakrishna R., Su Y.Z., Chen Z.H., Weiss M.H., and Couldwell W.T. Inhibition of cellular growth and induction of apoptosis in pituitary adenoma cell lines by the protein kinase C inhibitor hypericin: potential therapeutic application. J. Neurosurg. 85 2 (1996) 329-334
21. Hussaini I.M., Trotter C., Zhao Y., Abdel-Fattah R., Amos S., Xiao A., Agi C.U., Redpath G.T., Fang Z., Leung G.K., Lopes M.B., and Laws Jr. E.R. Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am. J. Pathol. 170 1 (2007) 356-365
22. Kazanietz M.G. Novel "nonkinase" phorbol ester receptors: the C1 domain connection. Mol. Pharmacol. 61 4 (2002) 759-767
23. Kenessey A., Sullivan E.A., and Ojamaa K. Nuclear localization of protein kinase C-alpha induces thyroid hormone receptor-alpha1 expression in the cardiomyocyte. Am. J. Physiol. Heart Circ. Physiol. 290 1 (2006) H381-H389
24. Knauf J.A., Ward L.S., Nikiforov Y.E., Nikiforova M., Puxeddu E., Medvedovic M., Liron T., Mochly-Rosen D., and Fagin J.A. Isozyme-specific abnormalities of PKC in thyroid cancer: evidence for post-transcriptional changes in PKC epsilon. J. Clin. Endocrinol. Metab. 87 2 (2002) 2150-2159
25. Kuriyama M., Taniguchi T., Shirai Y., Sasaki A., Yoshimura A., and Saito N. Activation and translocation of PKCdelta is necessary for VEGF-induced ERK activation through KDR in HEK293T cells. Biochem. Biophys. Res. Commun. 325 3 (2004) 351-843
26. Lachowicz A., and Rebas E. Gender differences in steroid modulation of angiotensin II-induced protein kinase C activity in anterior pituitary of the rat. Biochem. Biophys. Res. Commun. 294 1 (2002) 95-100
27. Leevers S.J., and Marshall C.J. Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J. 11 2 (1992) 569-574
28. Lehoux J.G., and Lefebvre A. Angiotensin II activates p44/42 MAP kinase partly through PKCepsilon in H295R cells. Mol. Cell. Endocrinol. 265-266 (2007) 121-125
29. Lin Y.F., Lee H.M., Leu S.J., and Tsai Y.H. The essentiality of PKCalpha and PKCbeta (I) translocation for CD14 (+)monocyte differentiation towards macrophages and dendritic cells, respectively. J. Cell. Biochem. 102 2 (2007) 429-441
30. MacEwan D.J., Johnson M.S., and Mitchell R. Protein kinase C isoforms in pituitary cells displaying differential sensitivity to phorbol ester. Mol. Cell. Biochem. 202 1/2 (1999) 85-90
31. Majumder P.K., Pandey P., Sun X., Cheng K., Datta R., Saxena S., Kharbanda S., and Kufe D. Mitochondrial translocation of protein kinase C delta in phorbol ester-induced cytochrome c release and apoptosis. J. Biol. Chem. 275 29 (2000) 21793-21796
32. Matsumoto E., Hatanaka M., Bohgaki M., and Maeda S. PKC pathway and ERK/MAPK pathway are required for induction of cyclin D1 and p21Waf1 during 12-o-tetradecanoylphorbol 13-acetate-induced differentiation of myeloleukemia cells. Kobe. J. Med. Sci. 52 6 (2006) 181-194
33. Mukdsi J.H., De Paul A.L., Muñoz S., Aoki A., and Torres A.I. Immunolocalization of Pit-1 in gonadotroph nuclei is indicative of the transdifferentiation of gonadotroph to lactotroph cells in prolactinomas induced by estrogen. Histochem. Cell. Biol. 121 6 (2004) 453-462
34. Mukdsi J.H., De Paul A.L., Gutiérrez S., Roth F.D., Aoki A., and Torres A.I. Subcellular localisation of VEGF in different pituitary cells. Changes of its expression in oestrogen induced prolactinomas. J. Mol. Histol. 36 8/9 (2005) 447-454
35. Mukdsi J.H., De Paul A.L., Petiti J.P., Gutiérrez S., Aoki A., and Torres A.I. Pattern of FGF-2 isoform expression correlated with its biological action in experimental prolactinomas. Acta Neuropathol. 112 4 (2006) 491-501
36. Ohno S., and Nishizuka Y. Protein kinase C isotypes and their specific functions: prologue. J. Biochem. 132 4 (2002) 509-511
37. Oomizu S., Takeuchi S., and Takahashi S. Stimulatory effect of insulin-like growth factor I on proliferation of mouse pituitary cells in serum-free culture. J. Endocrinol. 157 1 (1998) 53-62
38. Pan Q., Bao L.W., Kleer C.G., Sabel M.S., Griffith K.A., Teknos T.N., and Merajver S.D. Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy. Cancer Res. 65 18 (2005) 8366-8371
39. Poole A.W., Pula G., Hers I., Crosby D., and Jones M.L. PKC-interacting proteins: from function to pharmacology. Trends Pharmacol. Sci. 25 10 (2004) 528-535
40. Qiu Z.H., and Leslie C.C. Protein kinase C-dependent and -independent pathways of mitogen-activated protein kinase activation in macrophages by stimuli that activate phospholipase A2. J. Biol. Chem. 269 30 (1994) 19480-19487
41. Quittau-Prévostel C., Delaunay N., Collazos A., Vallentin A., and Joubert D. Targeting of PKCalpha and epsilon in the pituitary: a highly regulated mechanism involving a GD (E)E motif of the V3 region. J. Cell. Sci. 117 1 (2004) 63-72
42. Sarkar D.K. Genesis of prolactinomas: studies using estrogen-treated animals. Front. Horm. Res. 35 (2006) 32-49
43. Schechtman D., and Mochly-Rosen D. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 20 44 (2001) 6339-6347
44. Sharma G.D., Kakazu A., and Bazan H.E. Protein kinase C alpha and epsilon differentially modulate hepatocyte growth factor-induced epithelial proliferation and migration. Exp. Eye Res. 85 2 (2007) 289-297
45. Shirai Y., and Saito N. Activation mechanisms of protein kinase C: maturation, catalytic activation, and targeting. J. Biochem. 132 5 (2002) 663-668
46. Srivastava J., Procyk K.J., Iturrioz X., and Parker P.J. Phosphorylation is required for PMA- and cell-cycle-induced degradation of protein kinase Cdelta. Biochem. J. 368 1 (2002) 349-355
47. Wang Y.H., and Maurer R.A. A role for the mitogen-activated protein kinase in mediating the ability of thyrotropin-releasing hormone to stimulate the prolactin promoter. Mol. Endocrinol. 13 7 (1999) 1094-1104
48. Weichert W., Gekeler V., Denkert C., Dietel M., and Hauptmann S. Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis. Int. J. Oncol. 23 3 (2003) 633-639
49. Wen-Sheng W., and Jun-Ming H. Activation of protein kinase C alpha is required for TPA-triggered ERK (MAPK) signaling and growth inhibition of human hepatoma cell HepG2. J. Biomed. Sci. 12 2 (2005) 289-296
50. Wu D., Foreman T.L., Gregory C.W., McJilton M.A., Wescott G.G., Ford O.H., Alvey R.F., Mohler J.L., and Terrian D.M. Protein kinase C epsilon has the potential to advance the recurrence of human prostate cancer. Cancer Res. 62 8 (2002) 2423-2429
51. Yamakawa K., and Arita J. Cross-talk between the estrogen receptor-, protein kinase A-, and mitogen-activated protein kinase-mediated signaling pathways in the regulation of lactotroph proliferation in primary culture. J. Steroid Biochem. Mol. Biol. 88 2 (2004) 123-130
52. Yoshida K. PKCdelta signaling: mechanisms of DNA damage response and apoptosis. Cell. Signal. 19 5 (2007) 892-901
53. Zhu Y., Dong Q., Tan B.J., Lim W.G., Zhou S., and Duan W. The PKCalpha-D294G mutant found in pituitary and thyroid tumors fails to transduce extracellular signals. Cancer Res. 65 11 (2005) 4520-4524
54. Zini N., Martelli A.M., Neri L.M., Bavelloni A., Sabatelli P., Santi S., and Maraldi N.M. Immunocytochemical evaluation of protein kinase C translocation to the inner nuclear matrix in 3T3 mouse fibroblasts after IGF-I treatment. Histochem. Cell. Biol. 103 6 (1995) 447-457